Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

The Center for Inquiry sues homeopathy company Boiron over alleged consumer deception 

By Brian Buntz | April 15, 2022

CFI/Boiron

CFI/Boiron

The nonprofit organization Center for Inquiry (CFI) is suing Boiron, one of the biggest manufacturers of homeopathic products. In a lawsuit invoking the District of Columbia Consumer Protection Procedures Act, CFI argues that Boiron sells scores of materially identical products composed of sugar pills and powders while claiming that the products treat or cure a range of conditions.

Headquartered in Messimy, France, Boiron sells products to treat conditions ranging from flu to insomnia. Based on the concept of “like cures like,” homeopathy uses highly-diluted amounts of substances to bring about a therapeutic effect. Homeopathy is also based on the principle that the more diluted a substance is, the more potent it tends to be.

There are currently no FDA-approved homeopathic products.

CFI alleges that Boiron profits by deceiving consumers. “Boiron knows its products are worthless junk, so they do everything they can to obscure the truth in order to offload their snake oil upon the unwitting, the ill-informed, and the vulnerable,” said CFI vice president and legal counsel Nick Little, in a press release.

“Boiron sells little pills of sugar with grandiose claims. It’s hard to believe anyone would try to pass off such junk as a surefire way to treat painful skin problems, heal mental health issues, and even to counteract menopause,” said CFI Staff Attorney Aaron D. Green, in a press release. “But Boiron has been doing just that by tricking consumers into risking their health and throwing away their money on its fancy faux ‘medicines.’ It’s time for Boiron and all homeopathy hucksters to be held accountable.”

Boiron did not immediately respond to a request for comment.

sacharum officinale

Image courtesy of Boiron.

CFI singled out Boiron’s selling of Saccharum Officinale, table sugar, as a treatment for nervous agitation in children after overindulgence.

CFI also argued that independent labs have concluded that four Boiron products had no traces of their purported active ingredients.

Earlier this year, CFI announced that it was suing Walmart and CVS for fraud over their sales of homeopathic products.

CFI was founded in 1991 by the author Paul Kurtz. In 2016, it merged with the Richard Dawkins Foundation for Reason and Science.

Homeopathic treatments remain popular in Boiron’s native France. The French government announced in 2019 that it would cut funding for homeopathic medicines.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Shimadzu
Shimadzu launches LabSolutions MD software for high-performance liquid chromatography
ProMed
ProMed Pharma begins preclinical testing of resorbable contraceptive implant
Quattroflow QF20kSU
PROXCYS downstream biosystems offer compact radial flow chromatography systems
Morningside Pharmaceuticals
Morningside Pharmaceuticals donates 60,000 packs of medicine to Ukraine

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards